Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management
- PMID: 31560998
- DOI: 10.1016/j.neulet.2019.134516
Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management
Abstract
Parkinson's disease (PD) is a multifactorial neurodegenerative disorder, affecting 3.7% of the population over 65 years of age. PD involves degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNPC) with deficiency of dopamine. Genetic factors like SNCA, PARK-2, PARK-7, PINK-1 and LRRK-2 as well as environmental toxins enhance alpha-synuclein, amyloid β (beta) and τ (tau) proteins aggregation. Moreover, oxidative stress, mitochondrial dysfunctioning, neuroinflammation, prion like phenomena, excitotoxicity, mutations etc are known to cause pathological insult in PD. Recently, facts indicates strong correlation between gut-brain axis and PD. The communication between the gastrointestinal system (GIT) and central nervous system is bidirectional and it is hypothesized that PD arises in the gut and spreads to brain via vagus nerve that helps to propagate the alpha-synuclein that target brain. The Lewy bodies are found in olfactory bulb, dorsal motor vagal nerve and the ENS of the gut indicate peripheral and central correlation. The alteration of gut microbial flora leads to GIT disturbance which cause neuroinflammation by prion alpha-synuclein expression and produces PD like symptoms. Persistent gut inflammation with spontaneous neuroinflammation is yet need to confirm but increased intestinal permeability and disrupt function of GIT is known to produce non-motor symptoms of PD. The present review is aimed to explore mechanistic approach for gut associated PD symptoms as well as use of probiotics and prebiotics as therapeutic approach to retain gut microbial flora and prevent PD like symptoms.
Keywords: Gut- Microbiota; Gut-brain axis; Parkinson’s disease; Prebiotics; Probiotics; Vagotomy.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Gut brain axis: an insight into microbiota role in Parkinson's disease.Metab Brain Dis. 2021 Oct;36(7):1545-1557. doi: 10.1007/s11011-021-00808-2. Epub 2021 Aug 9. Metab Brain Dis. 2021. PMID: 34370175 Review.
-
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.Int J Mol Sci. 2018 Jun 6;19(6):1689. doi: 10.3390/ijms19061689. Int J Mol Sci. 2018. PMID: 29882798 Free PMC article. Review.
-
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.Front Immunol. 2019 Feb 15;10:239. doi: 10.3389/fimmu.2019.00239. eCollection 2019. Front Immunol. 2019. PMID: 30828335 Free PMC article. Review.
-
The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.Cell Mol Neurobiol. 2022 Mar;42(2):315-332. doi: 10.1007/s10571-021-01066-7. Epub 2021 Mar 2. Cell Mol Neurobiol. 2022. PMID: 33649989 Review.
-
Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.Curr Pharm Des. 2022;28(37):3049-3067. doi: 10.2174/1381612828666221003112300. Curr Pharm Des. 2022. PMID: 36200207 Review.
Cited by
-
The Correlation Between Heart Failure and Gut Microbiome Metabolites.Infect Microbes Dis. 2020 Nov 4;2(4):136-143. doi: 10.1097/IM9.0000000000000042. eCollection 2020 Dec. Infect Microbes Dis. 2020. PMID: 38630083 Free PMC article. Review.
-
Management of Gastrointestinal Symptoms in Parkinson's Disease: A Comprehensive Review of Clinical Presentation, Workup, and Treatment.J Clin Gastroenterol. 2024 Mar 1;58(3):211-220. doi: 10.1097/MCG.0000000000001961. J Clin Gastroenterol. 2024. PMID: 38260966 Free PMC article. Review.
-
Multidirectional associations between the gut microbiota and Parkinson's disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway.Front Cell Infect Microbiol. 2023 Dec 15;13:1296713. doi: 10.3389/fcimb.2023.1296713. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38173790 Free PMC article. Review.
-
Helicobacter pylori infection and Parkinson's Disease: etiology, pathogenesis and levodopa bioavailability.Immun Ageing. 2024 Jan 2;21(1):1. doi: 10.1186/s12979-023-00404-1. Immun Ageing. 2024. PMID: 38166953 Free PMC article. Review.
-
New Pieces for an Old Puzzle: Approaching Parkinson's Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics.Nutrients. 2023 Jun 16;15(12):2775. doi: 10.3390/nu15122775. Nutrients. 2023. PMID: 37375679 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous